The bacterial resistance of the national action plan to 2020 for the development of new antibacteria-headache怎么读�

The bacterial resistance of the national action plan: to 2020 for the development of new antibacterial drugs – Beijing, Beijing, August 25, the national health and Family Planning Commission and other 14 departments recently jointly issued the "curb bacterial resistance national action plan (2016-2020)". "Action plan" clearly, implementation strategies and measures for the comprehensive treatment from the national level, to strengthen the supervision of all aspects of research and development, production, distribution, antimicrobial application and environmental protection, strengthen publicity and education and international exchanges and cooperation, to deal with risks and challenges of bacterial resistance. By 2020, we can achieve 6 specific indicators in the development of new drugs, prescription drugs, monitoring and evaluation, clinical application, veterinary drug use and training and education. The paper pointed out that China is the production and use of antibacterial drugs. Antibiotics are widely used in medical and health, agricultural farming areas, in the treatment of infectious diseases to save the lives of patients, improve the efficiency of breeding and animal epidemic disease prevention and control to protect public health and safety, played an important role. However, due to the new antibacterial drug development ability is insufficient, pharmacies over-the-counter sales of antibiotics, medical and aquaculture field unreasonable application of antibacterial drugs, pharmaceutical waste emissions of non-compliance, public awareness of rational use of the various factors, the problem of bacterial resistance has become increasingly prominent. The paper suggests that the implementation of strategies and measures for the comprehensive treatment from the national level, to strengthen the supervision of all aspects of research and development, production, distribution, antimicrobial application and environmental protection, strengthen publicity and education and international exchanges and cooperation, to deal with risks and challenges of bacterial resistance. By 2020: (a) for the development of new antibiotics listed 1-2, new diagnostic equipment and reagents 5-10. (two) the proportion of retail pharmacies with prescription sales of antimicrobial drugs basically reached full coverage. Provinces (autonomous regions and municipalities) with veterinary prescription sales of antimicrobial drugs reached 50%. (three) improve the medical institutions, animal antibiotic use and bacterial resistance monitoring network; construction of bacterial resistance and strain reference laboratory center; establish the application of antibacterial drugs and drug resistance of bacteria control evaluation system of medical treatment, aquaculture field. (four) the establishment of the management system of clinical application of antibacterial drugs in hospitals at or above the level of two in China has been effectively controlled. (five) the use of antibacterial drugs or drug resistance to cross resistance to antibiotics as animal growth promoting application gradually withdraw; the main source of drug resistance of bacteria growth rate has been effectively controlled. (six) complete the rational use of drugs on the antibacterial training of medical personnel, first-line veterinary and aquaculture aquaculture practitioners; the full implementation of rational use of antimicrobial agents in science education in primary and middle schools; to carry out the rational use of antimicrobial drugs publicity week. "Action plan" also puts forward the main measures for the prevention and control of bacterial resistance includes 9 aspects: one is to exert the advantages of joint prevention and control, fulfill the duties of the Department; the two is to increase the antibacterial drug related research and development efforts; the three is to strengthen the management of antimicrobial drug supply security; the four is to strengthen the application of antibacterial drugs and drug control system; five to improve the application of antibiotics and bacterial drug resistance monitoring system; the six is to enhance the professional capacity of prevention and control of bacterial resistance; seven is a plus.相关的主题文章: